23andMe Adds $9M to VC Round

23andMe, the Mountain View, CA-based maker of consumer-oriented genetic tests, said today it has raised another $9 million to top off its Series C venture round at a total of $31 million. MPM Capital joined the investment round, and MPM’s Ashley Ledbetter Dombkowski is joining the company’s board in connection with the financing. 23andMe said back in November that it had raised the first $22 million of this round from Johnson & Johnson Development Corporation, New Enterprise Associates, and Google Ventures. Today’s announcement also says that Roche Venture Fund participated. The financing “will enable us to bring the vision of personalized medicine to consumers faster,” 23andMe co-founder and CEO Anne Wojcicki said in a statement.

Author: Luke Timmerman

Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.